ArticleCureus2025
Percutaneous Cryoablation of Elastofibroma Dorsi in a 73-Year-Old Woman: A Novel Minimally Invasive Alternative.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Elastofibroma dorsi: imaging-guided minimally invasive treatment using percutaneous COSkeletal radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elastofibroma dorsi (EFD) is a benign soft-tissue pseudotumor typically managed with surgical excision. Minimally invasive ablation techniques have not been previously described for this entity. We report the case of a 73-year-old active woman who presented with a left infrascapular mass confirmed on biopsy as an elastofibroma. To preserve shoulder mobility and avoid extensive surgery, CT-guided percutaneous cryoablation was performed using three cryoprobes with pneumodissection to protect adjacent soft tissues. The procedure was well tolerated, and the patient was discharged the following day. At one-month follow-up, she reported significant improvement of shoulder discomfort, reduction of the palpable lump, and full return to activity. This represents, to our knowledge, the first reported instance of EFD successfully treated with percutaneous cryoablation. This minimally invasive approach appears to offer an effective, low-morbidity alternative to surgical excision for selected patients, preserving function and reducing recovery time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.